ADMA Biologics Inc vs EPR Properties — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while EPR Properties trades at $60 (market cap $4.58B). The key difference: EPR Properties is far larger — about 2.1× ADMA Biologics Inc's market cap, and EPR Properties pays a 6.22% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | EPR | |
|---|---|---|
Market Cap | $2.22B | $4.58B |
Sector | Health | Real Estate |
52-Week High | $20.38 | $64.32 |
52-Week Low | $7.60 | $48.71 |
Enterprise Value | $2.29B | $8.09B |
Dividend Yield | — | 6.22% |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →